Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Sernova Corp. buy Mario11

Sernova Corp.
Start price
€0.88
13.10.21 / 100%
Target price
€7.00
13.10.22
Performance (%)
7.44%
End price
€0.95
14.06.22
Summary
This prediction ended on 14.06.22 with a price of €0.95. With a performance of 7.44%, the BUY prediction by Mario11 for Sernova Corp. closed with a slight gain. Mario11 has 100% into this prediction

Sernova Corp (WKN A0LBCR) is an innovative biotechnology company specializing in the development of regenerative medicine therapies. Focused on improving the treatment of chronic diseases, Sernova utilizes its proprietary Cell Pouch System™ - an implantable and scalable medical device - to house therapeutic cells for the long-term treatment of metabolic, hematologic, and neurological disorders. Listed on various stock exchanges, including Canada's TSX Venture Exchange (TSX-V), the Frankfurt Stock Exchange (FRA), and U.S. OTC (OTC:SEOVF), Sernova is driven by a mission to dramatically improve the outcomes and lives of individuals living with chronic diseases, while simultaneously offering a lucrative investment opportunity for those that believe in the potential of regenerative medicine.

Performance without dividends (%)
Name 1w 1m 1y
Sernova Corp. -5.704% -5.704% -58.635%
iShares Core DAX® 4.094% 4.888% 17.421%
iShares Nasdaq 100 1.424% -0.445% 37.618%
iShares Nikkei 225® -1.572% -4.911% 12.951%
iShares S&P 500 1.822% 0.776% 29.182%

According to Mario11 what are the pros and cons of Sernova Corp. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
Small challenges to pay loans and raise capital
Very high dividend yield expected
ROE higher than 15% per year
Very positive Cash Flow expected
Top Rating
Undervalued
High Investments for future growth
Very valuable balance sheet
Small Risks for its business
Management is a major shareholder
Very capable Management
Leading role in innovation
Strong uniques
Sustainability is very important
Very differentiated customer and product portfolio
Growths much faster than the competition
Very good company culture
Market Leader or Top 3
Very Future proof/growth oriented business model
Very small cyclical dependencies
Well known brand
Cons

Comments by Mario11 for this prediction

In the thread Sernova Corp. diskutieren
Prediction Buy
Perf. (%) 7.44%
Target price 7.000
Change
Ends at 13.10.22

Buy mit Kursziel 7,0

Mario11 
0
Report Share
13.10.21